Nadeem Wajih, Ph.D.
Assistant Professor, Cardiology
Academic: 336-713-7086 | Department: 336-716-6674
Wajih N, Cheng H-J, Zhou P, Daunais JB, Friedman DP, Little WC, Grant KA, Cheng CP. Downregulation of SR Ca2+-ATPase as a contributing cause of impaired cardiomyocyte basal and beta-adrenergic regulation of [Ca2+]i with myocyte dysfunction in monkeys with chronic heavy alcohol consumption [abstract]. Circulation. 2011;124(21 Suppl):A9254.
Cheng H-J, Zhou P, Zhao W, Wajih N, Han Q-H, Little WC, Cheng CP. Upregulation of cardiac urotensin II (UII) exacerbates UII stimulation-induced negative modulation on myocyte contractile function and Ca2+ current in streptozotocin-induced diabetic rats [abstract]. Circulation. 2011;124(21 Suppl):A9259.
Wajih N. Vitamin K epoxide reductase complex 1 (vkorc1) a new insight into the molecular design, operation and mechanism of warfarin inhibition [abstract]. Circulation. 2011;124(21 Suppl):A16308.
Wajih N. The vitamin K-dependent posttranslational gamma carboxylation system: a new model of its molecular design, operation, and wafarin inhibition [abstract]. Arterioscler Thromb Vasc Biol. 2010;30(11):e219.
Wajih N, Wallin R, Sane DC. Hyperglycemia induces vascular calcification in human aortic smooth muscle cells in vitro by upregulating the osteoblastic markers and inhibiting the Gla modification of Gla protein, the inhibitor of calcification [abstract]. Arterioscler Thromb Vasc Biol. 2010;30(11):e272.
Wajih N, Sane D, Wallin R. The role of protein kinase C activation in the regulation of warfarin-sensitive vitamin K epoxide reductase: evidence that human VKOR is a phosphoserine protein [abstract]. Arterioscler Thromb Vasc Biol. 2009;29(7):e56.
Wajih N, Wallin R, Sane D. Elevated glucose impairs warfarin-sensitive enzyme vitamin K epoxide reductase activity by activating protein kinase C [abstract]. Arterioscler Thromb Vasc Biol. 2009;29(7):e65.
Wajih N. Regulation of vitamin K-dependent epoxide reductase by protein disulphide isomerase [abstract]. Circulation. 2006;114(18 Suppl):30.
Wallin R, Wajih N, Owen J. Enhanced synthesis of functional recombinant factors IX and VII by BHK cells engineered to overexpress VKORC1 combined with siRNA silencing of the gamma-carboxylation inhibitor calumenin [abstract]. Blood. 2006;108(11 Pt 1):485a.
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.